TargetMol

Triaziquone

Product Code:
 
TAR-T34927
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T34927-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T34927-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T34927-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Triaziquone is an alkylating agent that can react with DNA to form intrastrand crosslinks.
CAS:
68-76-8
Formula:
C12H13N3O2
Molecular Weight:
231.255
Purity:
0.98
SMILES:
O=C1C=C(N2CC2)C(=O)C(N2CC2)=C1N1CC1

References

Huang CH, Kuo HS, Liu JW, Lin YL. Synthesis and antitumor evaluation of novel bis-triaziquone derivatives. Molecules. 2009 Jun 29;14(7):2306-16. doi: 10.3390/molecules14072306. PubMed PMID: 19633605. Oud JL, de Jong JH, de Rooij DG. A sequential analysis of meiosis in the male mouse using a restricted spermatocyte population obtained by a hydroxyurea/triaziquone treatment. Chromosoma. 1979 Feb 21;71(2):237-48. PubMed PMID: 371933. Oud JL, Peters PW. A sequential screening of the cytogenetic damage induced by triaziquone. Mutat Res. 1978 Oct;54(2):175-84. PubMed PMID: 362189. Lin YL, Su YT, Chen BH. A study on inhibition mechanism of breast cancer cells by bis-type triaziquone. Eur J Pharmacol. 2010 Jul 10;637(1-3):1-10. doi: 10.1016/j.ejphar.2010.03.034. Epub 2010 Apr 2. PubMed PMID: 20371239.